Medical Devices

The prestigious medical center's adoption of the XTRAC laser signals a major shift in treating chronic skin disease and expands hope for millions of patients.

New data on Spyre Therapeutics' SPY003 suggests a twice-yearly shot for IBD is possible, part of a broader strategy to challenge market giants.

The NYC-based private equity firm's oversubscribed Fund IX far exceeds its predecessor, showing robust investor confidence in its long-term strategy.

Bausch + Lomb beats Q4 revenue forecasts, propelled by its blockbuster dry eye drug MIEBO, and issues a confident financial outlook for 2026.

AcuityMD's new Salesforce integration promises to eliminate data silos and boost sales for MedTech firms, marking a strategic leap for the AI unicorn.

A new AI-native system, Isaac PracticeOS, promises to replace up to ten dental software tools, automating claims, scheduling, and patient communications.

A new biotech emerges with massive funding and a next-gen 'shuttle' to deliver safer, more effective Alzheimer's therapies directly to the brain.

Positive early trial data for ZP9830 shows promise for a new class of targeted autoimmune therapies, marking a strategic pivot for Zealand Pharma.

Photocure reports robust Q4 earnings and a strong 2026 forecast, while pivoting to an AI-driven future for bladder cancer diagnostics and global expansion.

With an 11% dividend hike and 22 years of growth, ADI proves its stability while investing heavily in the future of AI, automotive, and healthcare.

Cindy Eckert's TIME100 nod follows a major FDA win for her libido drug, Addyi, but spotlights a decade-long battle over efficacy, safety, and equality.

With over 2 million visitors at Expo 2025, Thailand showcased breakthrough medical tech. But can it translate this success into a global healthcare powerhouse?

Genmab posts record 2025 revenue, driven by cancer drug sales and a major acquisition, setting an ambitious, investment-heavy course for 2026.

Primex Inc. hires a life sciences expert to drive its OneVue Sense solution deeper into the critical and highly regulated healthcare and biopharma markets.

A new study shows an AI-powered device can identify infants at high risk for atopic dermatitis at birth, paving the way for proactive, preventative care.

Integrity College of Health's maximum six-year reaccreditation offers a key validation for parent company Legacy Education amid a shifting regulatory climate.

The largest study of its kind reveals metabolic signatures that predict severe neurotoxicity in CAR T-cell patients, paving the way for safer treatments.

A key Medtrade 2026 panel led by Synapse Health will unite industry leaders to chart the future of value-based care in the DME market.

With a new CTO and fortified legal and quality chiefs, Integra LifeSciences is making a bold play to accelerate innovation and shore up compliance.

Two Pasco County communities are among the nation's top sellers. Their secret? A 15-acre lagoon, a residential farm, and a new vision for community life.